HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Baris Turkbey Selected Research
Baris Turkbey Research Topics
Disease
79
Prostatic Neoplasms (Prostate Cancer)
07/2022 - 04/2009
65
Neoplasms (Cancer)
06/2022 - 05/2008
12
Neoplasm Metastasis (Metastasis)
05/2022 - 12/2009
3
Residual Neoplasm
01/2022 - 11/2021
3
Hypoxia (Hypoxemia)
08/2017 - 02/2014
2
Multiple Myeloma
11/2021 - 01/2021
2
Adenocarcinoma
01/2021 - 05/2017
2
Rupture
02/2020 - 03/2007
2
Kidney Neoplasms (Kidney Cancer)
01/2020 - 03/2009
2
Urogenital Neoplasms
01/2020 - 12/2018
2
Kidney Diseases (Kidney Disease)
01/2018 - 01/2018
2
Portal Hypertension
01/2018 - 01/2018
2
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2016 - 03/2014
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 10/2014
2
Extranodal Extension
01/2016 - 07/2015
2
Hemorrhage
01/2013 - 08/2008
2
Acute Cholecystitis
01/2011 - 09/2009
2
Cysts
03/2009 - 09/2008
1
Smoldering Multiple Myeloma
11/2021
1
Urinary Bladder Neoplasms (Bladder Cancer)
11/2021
1
Edema (Dropsy)
10/2021
1
COVID-19
10/2021
1
Leukopenia
01/2021
1
Hypogonadism (Hypergonadotropic Hypogonadism)
04/2020
1
Hypothyroidism
01/2020
1
Hyperthyroidism
01/2020
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020
1
Fatigue
01/2020
1
Iron Overload
01/2020
1
Weight Gain
01/2020
1
Paraganglioma (Paragangliomas)
01/2020
Drug/Important Bio-Agent (IBA)
29
Prostate-Specific Antigen (Semenogelase)
IBA
01/2022 - 03/2011
15
Antigens
IBA
01/2022 - 01/2011
9
Biomarkers (Surrogate Marker)
IBA
01/2022 - 03/2011
9
Contrast Media
IBA
01/2021 - 08/2008
5
Androgens
IBA
01/2022 - 01/2019
5
Biological Products
IBA
10/2021 - 04/2012
5
ferric oxide (iron oxide)
IBA
09/2018 - 07/2011
4
Coloring Agents (Dyes)
IBA
06/2022 - 01/2021
4
Ferrosoferric Oxide (Magnetite)
FDA Link
01/2020 - 07/2015
4
Sorafenib (BAY 43-9006)
FDA Link
08/2017 - 03/2011
3
Fluorides
IBA
01/2022 - 11/2018
3
Antibodies
IBA
01/2022 - 01/2011
3
enzalutamide
IBA
01/2022 - 01/2021
3
DNA (Deoxyribonucleic Acid)
IBA
12/2021 - 12/2017
3
Ligands
IBA
10/2021 - 11/2016
3
Radioisotopes (Radionuclides)
IBA
01/2020 - 11/2016
3
Acids
IBA
01/2020 - 03/2014
3
Proteins (Proteins, Gene)
FDA Link
01/2018 - 02/2014
3
Indicators and Reagents (Reagents)
IBA
10/2017 - 05/2008
3
Capsules (Microcapsules)
IBA
01/2017 - 10/2015
2
Monoclonal Antibodies
IBA
06/2022 - 10/2014
2
Immune Checkpoint Inhibitors
IBA
06/2022 - 01/2021
2
Hematoxylin (Haematoxylon)
IBA
01/2022 - 01/2020
2
Eosine Yellowish-(YS) (Eosin)
IBA
01/2022 - 01/2020
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2022 - 11/2021
2
Oxygen (Dioxygen)
IBA
10/2021 - 02/2014
2
Solutions
IBA
04/2020 - 12/2013
2
Pharmaceutical Preparations
IBA
01/2020 - 12/2014
2
Sodium Fluoride (Ossin)
FDA Link
06/2018 - 01/2017
2
Enzymes
IBA
01/2018 - 09/2015
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2017 - 03/2011
2
Fluconazole (Zonal)
FDA Link
Generic
12/2015 - 12/2012
2
gadobenic acid (gadobenate dimeglumine)
FDA Link
01/2011 - 09/2009
1
Silicon Dioxide (Silica)
FDA Link
Generic
06/2022
1
phthalocyanine
IBA
06/2022
1
2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acid
IBA
01/2022
1
Lenalidomide (CC 5013)
FDA Link
11/2021
1
carfilzomib
IBA
11/2021
1
Fluorine-18
IBA
11/2021
1
gadolinium ethoxybenzyl DTPA
FDA Link
11/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
11/2021
1
Ascorbic Acid (Vitamin C)
FDA Link
Generic
10/2021
1
Therapeutic Uses
IBA
10/2021
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2021
1
silicon phthalocyanine
IBA
10/2021
1
C-Reactive Protein
IBA
01/2021
1
Tensins
IBA
01/2021
1
avelumab
IBA
01/2021
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2021
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2021
1
Procalcitonin
IBA
01/2021
1
Testosterone (Sustanon)
FDA Link
04/2020
1
Mucins
IBA
02/2020
1
Choline (Choline Chloride)
IBA
01/2020
1
Thyroxine (Levothyroxine)
FDA Link
Generic
01/2020
1
Peptide Receptors (Peptide Receptor)
IBA
01/2020
1
lutetium Lu 177 dotatate
IBA
01/2020
1
Lutetium
IBA
01/2020
1
Prostaglandins A
IBA
01/2020
Therapy/Procedure
39
Therapeutics
06/2022 - 09/2008
29
Prostatectomy (Retropubic Prostatectomy)
02/2022 - 11/2011
14
Radiotherapy
05/2022 - 05/2012
5
Aftercare (After-Treatment)
12/2021 - 08/2013
3
Laser Therapy (Surgery, Laser)
05/2021 - 04/2018
3
Lymph Node Excision (Lymph Node Dissection)
10/2018 - 05/2015
2
Brachytherapy
07/2022 - 01/2012
2
Castration
11/2021 - 12/2018
1
Salvage Therapy
09/2020
1
Cystectomy
01/2020